Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension,Journal of Child and Adolescent Psychopharmacology

当前位置： X-MOL 学术 › J. Child Adolesc. Psychopharmacol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension
Journal of Child and Adolescent Psychopharmacology ( IF 1.5 ) Pub Date : 2021-11-16 , DOI: 10.1089/cap.2021.0034
Margaret D Weiss ₁ , Andrew J Cutler ₂ , Scott H Kollins _{3,

4} , Graeme A E Donnelly ₅

Affiliation

Objectives: To study the safety and efficacy of the long-acting methylphenidate formulation PRC-063 in adolescents with attention-deficit/hyperactivity disorder (ADHD).

中文翻译：